1. Gale RP: Advances in the treatment of acute myelogenous leukemia. N Engl J Med 300:1189–1199, 1979
2. Skipper HE, Schabel FM Jr, Wilcox WS: Experimental evaluation of potential anticancer agents. XXI. Scheduling of arabinosylcytosine to take advantage of its S-phase specificity against leukemia cells. Cancer Chemother Rep 51:125–165, 1967
3. Southwest Oncology Group: Cytarabine for acute leukemia in adults. Arch Intern Med 133:251–259, 1974
4. Rai KR, Holland JF, Glidewell OJ: Treatment of acute myelocytic leukemia: A study by Cancer and Leukemia Group B. Blood 58:1203–1212, 1981
5. Weil M, Glidewell OJ, Jacquillat C, Levy R, Serpick AA, Wiernik PH, Cuttner J, Hoogstraten B, Wasserman L, Ellison RR, Gailani S, Brunner K, Silver RT, Rege VB, Cooper R, Lowenstein L, Nissen NI, Haurani F, Blom J, Boiron M, Bernard J, Holland JF: Daunorubicin in the therapy of acute granulocyte leukemia. Cancer Res 330:921–928, 1973